Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fouque

Showing results (541-550 of 656) with videos related to

Pageof 66
Sort By:
QJM : Monthly Journal of the Association of Physicians|October 9, 2019
Acute renal and splenic infarctions: a reviewE Weber, F Grangeon, Q Reynaud, et al.
British Journal of Clinical Pharmacology|August 16, 2018
Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohortSolène M Laville, Marie Metzger, Bénédicte Stengel, et al.
Diabetes & Metabolism|May 1, 2018
Impact of sex and glucose-lowering treatments on hypoglycaemic symptoms in people with type 2 diabetes and chronic kidney disease. The French Chronic Kidney Disease - Renal Epidemiology and Information Network (CKD-REIN) StudyB Balkau, M Metzger, F Andreelli, et al.
Clinical Nephrology|September 24, 2010
"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational studyM Vervloet, V Bencova, F Malberti, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2017
Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During HemodialysisChristophe Marçais, Delphine Maucort-Boulch, Jocelyne Drai, et al.
Kidney International Reports|July 18, 2025
Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKDMargaux Costes-Albrespic, Natalia Alencar de Pinho, Islam Amine Larabi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 2019
Children of a lesser god: exclusion of chronic kidney disease patients from clinical trialsCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 26, 2015
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?S Pelletier, C B Confavreux, J Haesebaert, et al.
Kidney International|May 24, 2013
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and MetabolismT Alp Ikizler, Noel J Cano, Harold Franch, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 3, 2020
Adverse Drug Reactions in Patients with CKDSolène M Laville, Valérie Gras-Champel, Julien Moragny, et al.
Pageof 66

Showing results (541-550 of 656) with videos related to

Sort By:
Pageof 66
QJM : Monthly Journal of the Association of Physicians|October 9, 2019
Acute renal and splenic infarctions: a reviewE Weber, F Grangeon, Q Reynaud, et al.
British Journal of Clinical Pharmacology|August 16, 2018
Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohortSolène M Laville, Marie Metzger, Bénédicte Stengel, et al.
Diabetes & Metabolism|May 1, 2018
Impact of sex and glucose-lowering treatments on hypoglycaemic symptoms in people with type 2 diabetes and chronic kidney disease. The French Chronic Kidney Disease - Renal Epidemiology and Information Network (CKD-REIN) StudyB Balkau, M Metzger, F Andreelli, et al.
Clinical Nephrology|September 24, 2010
"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational studyM Vervloet, V Bencova, F Malberti, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2017
Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During HemodialysisChristophe Marçais, Delphine Maucort-Boulch, Jocelyne Drai, et al.
Kidney International Reports|July 18, 2025
Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKDMargaux Costes-Albrespic, Natalia Alencar de Pinho, Islam Amine Larabi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 2019
Children of a lesser god: exclusion of chronic kidney disease patients from clinical trialsCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 26, 2015
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?S Pelletier, C B Confavreux, J Haesebaert, et al.
Kidney International|May 24, 2013
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and MetabolismT Alp Ikizler, Noel J Cano, Harold Franch, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 3, 2020
Adverse Drug Reactions in Patients with CKDSolène M Laville, Valérie Gras-Champel, Julien Moragny, et al.
Pageof 66